Skip to main content
RI

RealNose Inc.

RealNose develops AI-trained, bioprogrammable olfactory sensors that utilize bionanotechnology to detect scent profiles for early prostate cancer diagnosis and Gleason scoring. This non-invasive method addresses the limitations of traditional diagnostic techniques, which are often invasive, costly, and lack accuracy.

Cambridge, United KingdomFounded 20234100+ followers
Updated 4 months ago

Funding

$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current prostate cancer detection methods, including PSA blood tests, digital rectal exams, and biopsies, are invasive, expensive, and often lack the necessary accuracy, leading to patient stress and unnecessary procedures. Existing diagnostic techniques also struggle with early detection and accurate Gleason scoring, which are critical for effective treatment planning.

Solution

RealNose is developing AI-trained, bioprogrammable olfactory sensors that mimic canine olfaction to detect scent profiles for early prostate cancer diagnosis and Gleason scoring. The technology utilizes bionanomaterials, machine learning, and bioprogrammable receptors to achieve high-accuracy trace odor detection from patient samples. This non-invasive method aims to provide a cost-effective and highly accurate alternative for early disease detection, potentially expanding to other types of cancer and conditions in the future. The RealNose platform creates an AI-driven electronic device capable of identifying scent signatures associated with prostate cancer.

Target Audience

The primary target audience includes healthcare providers, diagnostic centers, and patients seeking a non-invasive and accurate method for early prostate cancer detection and Gleason scoring.

Features

  • AI-trained olfactory sensors using bionanotechnology
  • Bioprogrammable receptors for mapping scent profiles
  • Non-invasive scent detection for early prostate cancer diagnosis
  • Gleason scoring capabilities for accurate disease assessment
  • Mimics canine olfaction for high-accuracy trace odor detection
  • Potential applications span from identifying contraband, explosives, and toxins, to monitoring biopharmaceutical fermenters and quality control of composite materials
This profile is AI-generated and may contain inaccuracies.